Share Talk - Exclusive Stock Market News and Articles
Olav Hellebo, CEO of ReNeuron Group plc (RENE.L) Interview
April 6, 2021
ReNeuron is a global leader in cell-based therapeutics, harnessing its unique stem cell technologies to develop 'off the shelf' stem cell treatments, without the need for immunosuppressive drugs. The Company's lead cell therapy candidate is in clinical development for the blindness-causing disease, retinitis pigmentosa.